Insider Transactions in Q3 2024 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.26%
|
$1,000,000
$100.5 P/Share
|
|
Sep 30
2024
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.76%
|
$270,000
$27.85 P/Share
|
|
Sep 23
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect |
2,000
-0.13%
|
$208,000
$104.43 P/Share
|
|
Sep 16
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,000
-3.0%
|
$776,000
$97.46 P/Share
|
|
Sep 16
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+16.23%
|
$144,000
$18.93 P/Share
|
|
Sep 16
2024
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
32,795
-6.47%
|
$3,213,910
$98.26 P/Share
|
|
Sep 09
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.1%
|
$261,000
$87.88 P/Share
|
|
Sep 09
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.63%
|
$18,000
$6.89 P/Share
|
|
Sep 03
2024
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.53%
|
$420,000
$84.72 P/Share
|
|
Sep 03
2024
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.55%
|
$90,000
$18.93 P/Share
|
|
Aug 30
2024
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.24%
|
$840,000
$84.79 P/Share
|
|
Aug 30
2024
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.76%
|
$270,000
$27.85 P/Share
|
|
Aug 26
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect |
2,000
-0.29%
|
$168,000
$84.71 P/Share
|
|
Aug 23
2024
|
Emily Conley |
SELL
Open market or private sale
|
Direct |
3,334
-57.08%
|
$283,390
$85.02 P/Share
|
|
Aug 23
2024
|
Emily Conley |
BUY
Exercise of conversion of derivative security
|
Direct |
3,334
+36.34%
|
$43,342
$13.79 P/Share
|
|
Aug 23
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,000
-24.83%
|
$935,000
$85.04 P/Share
|
|
Aug 23
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+11.74%
|
$253,000
$23.39 P/Share
|
|
Aug 23
2024
|
Henry E. Pelish Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,500
-13.71%
|
$892,500
$85.08 P/Share
|
|
Aug 08
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.69%
|
$204,000
$68.01 P/Share
|
|
Aug 08
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.63%
|
$18,000
$6.89 P/Share
|
|
Aug 01
2024
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.74%
|
$390,000
$78.29 P/Share
|
|
Aug 01
2024
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.55%
|
$90,000
$18.93 P/Share
|
|
Jul 31
2024
|
Alexandra Balcom Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.01%
|
$790,000
$79.24 P/Share
|
|
Jul 31
2024
|
Alexandra Balcom Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.76%
|
$270,000
$27.85 P/Share
|
|
Jul 29
2024
|
Matthew Shair |
SELL
Open market or private sale
|
Indirect |
2,000
-0.22%
|
$160,000
$80.33 P/Share
|
|
Jul 15
2024
|
Emily Conley |
SELL
Open market or private sale
|
Direct |
5,000
-22.38%
|
$400,000
$80.76 P/Share
|
|
Jul 15
2024
|
Emily Conley |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+39.98%
|
$65,000
$13.79 P/Share
|
|
Jul 12
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,000
-15.27%
|
$480,000
$80.16 P/Share
|
|
Jul 12
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+13.25%
|
$162,000
$27.85 P/Share
|
|
Jul 09
2024
|
Henry E. Pelish Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,100
+14.61%
|
-
|
|
Jul 08
2024
|
Deborah Ann Miller Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.82%
|
$219,000
$73.07 P/Share
|
|
Jul 08
2024
|
Deborah Ann Miller Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.63%
|
$18,000
$6.89 P/Share
|
|
Jul 01
2024
|
Darlene Noci Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.62%
|
$375,000
$75.83 P/Share
|
|
Jul 01
2024
|
Darlene Noci Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.55%
|
$90,000
$18.93 P/Share
|